Home » Stocks » Conformis

Conformis, Inc. (CFMS)

Stock Price: $0.740 USD -0.010 (-1.27%)

Updated Aug 6, 2020 9:43 AM EDT - Market open

Stock Price Chart

Key Info

Market Cap	52.90M
Revenue (ttm)	73.26M
Net Income (ttm)	-30.25M
Shares Out	71.48M
EPS (ttm)	-0.46
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Dividend Yield	n/a

Stock Quote

Trading Day	Aug 6, 2020
Last Price	$0.740
Previous Close	$0.750
Change ($)	-0.010
Change (%)	-1.27%
Day's Open	0.779
Day's Range	0.740 - 0.779
Day's Volume	98,706
52-Week Range	0.500 - 2.680

More Stats

Market Cap	52.90M
Enterprise Value	56.94M
Earnings Date (est)	Oct 28, 2020
Ex-Dividend Date	n/a
Shares Outstanding	71.48M
Float	54.41M
EPS (basic)	-0.46
EPS (diluted)	-0.46
FCF / Share	-0.10

Dividend	n/a
Dividend Yield	n/a
Earnings Yield	n/a
FCF Yield	n/a
Payout Ratio	n/a
Shares Short	1.38M
Short Ratio	0.95
Short % of Float	1.25%
Beta	2.12

PE Ratio	n/a
Forward PE	n/a
P/FCF Ratio	n/a
PS Ratio	0.72
PB Ratio	5.81
Revenue	73.26M
Operating Income	-26.61M
Net Income	-30.25M
Free Cash Flow	-6.72M

Net Cash	-4.04M
Net Cash / Share	-0.06
Gross Margin	50.15%
Operating Margin	-36.33%
Profit Margin	-41.30%
FCF Margin	-9.18%
ROA	-25.98%
ROE	-151.62%
ROIC	-50.30%

Stats based on trailing-twelve-month (ttm) numbers.

Analyst Summary

Analyst Ratings (0)

Buy	0
Overweight	0
Hold	0
Underweight	0
Sell	0

What these ratings mean

Analyst Consensus: n/a

Price Target

$2.33*

(214.86% upside)

Low

2.00

Current: $0.740

High

3.00

Target: 2.33

*Average 12-month price target from 3 stock analysts.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Year	2019	2018	2017	2016	2015	2014	2013
Revenue	77.43	89.79	78.12	79.90	66.89	48.19	34.60
Revenue Growth	-13.77%	14.94%	-2.23%	19.45%	38.81%	39.28%	-
Gross Profit	36.74	48.49	28.81	26.71	21.79	15.81	7.31
Operating Income	-25.13	-38.69	-55.85	-56.14	-55.96	-45.43	-47.31
Net Income	-28.48	-43.37	-53.58	-57.59	-57.25	-45.72	-47.89
Shares Outstanding	64.12	58.89	43.34	41.52	21.99	4.24	4.00
Earnings Per Share	-0.44	-0.74	-1.24	-1.39	-2.60	-10.78	-11.98
Operating Cash Flow	-2.84	-25.18	-37.86	-49.13	-54.45	-43.54	-46.83
Capital Expenditures	-2.93	-4.06	-5.23	-7.16	-4.64	-2.61	-4.11
Free Cash Flow	-5.76	-29.24	-43.09	-56.29	-59.09	-46.15	-50.94
Cash & Equivalents	26.86	24.09	45.69	65.80	118	42.34	59.77
Total Debt	26.16	14.79	29.67	-	0.48	10.62	3.11
Net Cash / Debt	0.69	9.30	16.02	65.80	117	31.72	56.66
Assets	72.40	62.98	93.80	113	159	71.28	83.89
Liabilities	56.05	26.78	47.29	18.76	18.16	21.45	14.93
Book Value	16.35	36.20	46.51	94.06	141	49.83	68.96

Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name	Conformis, Inc.
Country	United States
Employees	262
CEO	Mark A. Augusti

Stock Information

Ticker Symbol	CFMS
Stock Exchange	NASDAQ
Sector	Healthcare
Industry	Medical Devices
Unique Identifier	NASDAQ: CFMS
IPO Date	July 1, 2015

Description

Conformis, Inc., a medical technology company, develops, manufactures, and sells joint replacement implants. The company offers personalized knee replacement products, including iTotal CR, a cruciate-retaining product; iTotal PS, a posterior cruciate ligament substituting product; iDuo, a personalized bicompartmental knee replacement system; and iUni, a personalized unicompartmental knee replacement product to treat the medial or lateral compartment of the knee. It also provides Conformis Hip System, a hip replacement product; and iJigs, a customized single-use patient-specific instrumentation. The company markets and sells its products to hospitals and other medical facilities through sales force, independent sales representatives, and distributors in the United States, Germany, the United Kingdom, Austria, Ireland, Switzerland, Singapore, Hong Kong, Malaysia, Monaco, Hungary, Spain, and Australia. Conformis, Inc. was founded in 2004 and is headquartered in Billerica, Massachusetts.